National Alliance on Mental Illness
page printed from http://www.nami.org/
(800) 950-NAMI; email@example.com
NAMI Presses CMS to Ensure that Atypical Antipsychotics are Included in the Upcoming Medicare Part B Competitive Acquisition Program (CAP)
August 4, 2005
Earlier this year, NAMI pushed the Centers for Medicare and Medicaid Services (CMS) to include atypical antipsychotic medications in the Part B CAP program covering non-self-injectible medications administered in physician offices and clinics. In July, CMS issued rules clarifying that antipsychotic medications will be included in the program. NAMI's letter to CMS is posted below.
Related FilesLetter to CMS Regarding Medicare (PDF File)